Open-source AI tool competes with leading proprietary models in medical diagnosis

Artificial intelligence can transform medicine in a myriad of ways, including its promise to act as a trusted diagnostic aide to busy clinicians.

PharmAla Received Guidance on ALA-002 from MHRA; Launches Clinical Program with University of Sydney | Psychedelic Invest

PharmAla Biotech Holdings Inc. (CSE: MDMA / OTC:PMBHF), a biotechnology company focused on the research, development, and manufacturing of novel MDXX class molecules (including MDMA),

July 25, 2023

MSD extends peptide collaboration with IRBM – Pharmaceutical Technology

IRBM claims its partnership with MSD has benefitted from recent advances in phage and mRNA display platforms. Source: Shutterstock / testing. Contract research organisation IRBM

June 23, 2023

Novo nabs over a third of diabetes market, a year ahead of schedule

Novo Nordisk’s GLP-1 drugs may have been the center of attention during its first-quarter earnings call, but the company’s broader diabetes portfolio beat its target

May 3, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.